Cytotoxic and genotoxic effects of 131 I and 60 Co in follicular thyroid cancer cell (WRO) with and without recombinant human thyroid-stimulating hormone treatment.

about

Cytotoxic and genotoxic effects of 131 I and 60 Co in follicular thyroid cancer cell (WRO) with and without recombinant human thyroid-stimulating hormone treatment.

Item

http://www.wikidata.org/entity/Q38701744

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Cytotoxic and genotoxic effect ...... stimulating hormone treatment.

@en

type

Item

label

Cytotoxic and genotoxic effect ...... stimulating hormone treatment.

@en

prefLabel

Cytotoxic and genotoxic effect ...... stimulating hormone treatment.

@en

P1476

Cytotoxic and genotoxic effect ...... stimulating hormone treatment.

@en

P2093

Daniel Perez Vieira

http://www.w3.org/2001/XMLSchema#string

Flávia Gomes Silva Valgôde

http://www.w3.org/2001/XMLSchema#string

Kayo Okazaki

http://www.w3.org/2001/XMLSchema#string

Maria Teresa Carvalho Pinto Ribela

http://www.w3.org/2001/XMLSchema#string

Márcia Augusta da Silva

http://www.w3.org/2001/XMLSchema#string

Paolo Bartolini

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular Targeted Therapies of Aggressive Thyroid Cancer

Mutations of the BRAF gene in human cancer

Molecular mechanisms of the origin of micronuclei from extrachromosomal elements

Two-step chromatographic purification of recombinant human thyrotrophin and its immunological, biological, physico-chemical and mass spectral characterization.

Conventional and molecular cytogenetics of human non-medullary thyroid carcinoma: characterization of eight cell line models and review of the literature on clinical samples.

Remedy for radiation fear - discard the politicized science.

Prognostic utility of BRAF mutation in papillary thyroid cancer.

BRAF V600E maintains proliferation, transformation, and tumorigenicity of BRAF-mutant papillary thyroid cancer cells

Expulsion of micronuclei containing amplified genes contributes to a decrease in double minute chromosomes from malignant tumor cells.

Targeting BRAFV600E with PLX4720 displays potent antimigratory and anti-invasive activity in preclinical models of human thyroid cancer.

P304

451-461

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/EM.22099

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28561379

http://www.w3.org/2001/XMLSchema#string